News + Filings Transactions
|
Sinha Uma
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/29/2023 | PROKIDNEY CORP. | | Grant | Director stock option (right to buy) | 48.1k | $10.56 | $508.2k | | 06/29/2023 |
| 07/11/2022 | PROKIDNEY CORP. | | Grant | Class A Ordinary Shares | 30k | $0.00 | $0 | | 07/11/2022 |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Disposition | Stock Option (Right to Buy) | 60k | $13.20 | $792k | | 01/26/2021 |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Other | Common Stock | 303.5k | $0.00 | $0 | | 01/26/2021 |
| 01/13/2021 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 572 | $122.27 | $69.9k | | 01/13/2021 |
| 01/13/2021 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 1.5k | $123.48 | $185k | | 01/13/2021 |
| 01/13/2021 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 4.9k | $124.72 | $615.4k | | 01/13/2021 |
| 01/13/2021 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 2k | $125.35 | $250.7k | | 01/13/2021 |
| 01/13/2021 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 300 | $126.39 | $37.9k | | 01/13/2021 |
| 01/13/2021 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 696 | $121.11 | $84.3k | | 01/13/2021 |
| 12/15/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 5.7k | $42.80 | $244.7k | | 12/15/2020 |
| 12/15/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 10.8k | $3.07 | $33.3k | | 12/15/2020 |
| 12/15/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 8.9k | $3.07 | $27.4k | | 12/15/2020 |
| 12/02/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 702 | $90.63 | $63.6k | | 12/02/2020 |
| 12/02/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 300 | $91.89 | $27.6k | | 12/02/2020 |
| 12/02/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 200 | $92.97 | $18.6k | | 12/02/2020 |
| 12/02/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 3.8k | $89.63 | $340.4k | | 12/02/2020 |
| 11/16/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Restricted Stock Units | 469 | $0.00 | $0 | | 11/16/2020 |
| 10/29/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 3.7k | $72.60 | $268.6k | | 10/29/2020 |
| 10/29/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 1.3k | $71.90 | $93.5k | | 10/29/2020 |
| 10/27/2020 | Eidos Therapeutics, Inc. | EIDX | Gift | Common Stock | 3k | $0.00 | $0 | | 01/26/2021 |
| 10/01/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 4.8k | $52.35 | $252.9k | | 09/30/2020 |
| 09/30/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 69 | $52.08 | $3.6k | | 09/30/2020 |
| 09/30/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 100 | $52.00 | $5.2k | | 09/30/2020 |
| 08/16/2020 | BridgeBio Pharma, Inc. | BBIO | Exercise | Restricted Stock Units | 468 | $0.00 | $0 | | 08/16/2020 |
| 06/01/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Restricted Stock Units | 7.5k | $0.00 | $0 | | 06/01/2020 |
| 05/31/2020 | Eidos Therapeutics, Inc. | EIDX | Grant | Common Stock | 444 | $41.57 | $18.5k | | 05/31/2020 |
| 05/19/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Common Stock | 1.5k | $0.00 | $0 | | 05/19/2020 |
| 05/19/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 5.4k | $1.25 | $6.7k | | 05/19/2020 |
| 05/19/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 49.4k | $0.16 | $7.9k | | 05/19/2020 |
| 05/19/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 49.8k | $0.34 | $16.9k | | 05/19/2020 |
| 05/19/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 3k | $3.35 | $10.1k | | 05/19/2020 |
| 12/18/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 1.7k | $63.31 | $107.8k | | 12/18/2019 |
| 12/18/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 825 | $62.49 | $51.6k | | 12/18/2019 |
| 12/18/2019 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 10k | $61.61 | $614.5k | | 12/18/2019 |
|
|